Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Merville

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Immunological Reviews|October 22, 2020
Understanding human γδ T cell biology toward a better management of cytomegalovirus infectionHannah Kaminski, Gabriel Marsères, Anaïs Cosentino, et al.
Clinical Transplantation|December 28, 2020
Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non-melanoma skin cancer after kidney transplantation, a pilot studyJulie Préterre, Jonathan Visentin, Morgane Saint Cricq, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2018
The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft lossMaxime Courant, Jonathan Visentin, Gabriel Linares, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 31, 2025
Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant RecipientsYoann Abadie, Jonathan Visentin, Elodie Wojciechowski, et al.
Journal of Clinical Microbiology|December 7, 2007
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipientsIsabelle Garrigue, Adélaïde Doussau, Julien Asselineau, et al.
Transplantation|April 6, 2011
Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the TranCept Switch studyHerwig-Ulf Meier-Kriesche, Pierre Merville, Helio Tedesco-Silva, et al.
Blood|June 10, 2008
Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infectionVincent Pitard, David Roumanes, Xavier Lafarge, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2023
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017Pierre Pfirmann, Isabelle Garrigue, Bertrand Chauveau, et al.
The Journal of Infectious Diseases|September 29, 2009
Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipientsLionel Couzi, Vincent Pitard, Sonia Netzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signalBenjamin Chaigne-Delalande, Gwendaline Guidicelli, Lionel Couzi, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Immunological Reviews|October 22, 2020
Understanding human γδ T cell biology toward a better management of cytomegalovirus infectionHannah Kaminski, Gabriel Marsères, Anaïs Cosentino, et al.
Clinical Transplantation|December 28, 2020
Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non-melanoma skin cancer after kidney transplantation, a pilot studyJulie Préterre, Jonathan Visentin, Morgane Saint Cricq, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2018
The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft lossMaxime Courant, Jonathan Visentin, Gabriel Linares, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 31, 2025
Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant RecipientsYoann Abadie, Jonathan Visentin, Elodie Wojciechowski, et al.
Journal of Clinical Microbiology|December 7, 2007
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipientsIsabelle Garrigue, Adélaïde Doussau, Julien Asselineau, et al.
Transplantation|April 6, 2011
Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the TranCept Switch studyHerwig-Ulf Meier-Kriesche, Pierre Merville, Helio Tedesco-Silva, et al.
Blood|June 10, 2008
Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infectionVincent Pitard, David Roumanes, Xavier Lafarge, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2023
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017Pierre Pfirmann, Isabelle Garrigue, Bertrand Chauveau, et al.
The Journal of Infectious Diseases|September 29, 2009
Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipientsLionel Couzi, Vincent Pitard, Sonia Netzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signalBenjamin Chaigne-Delalande, Gwendaline Guidicelli, Lionel Couzi, et al.
Pageof 13